Because OB-002 could have immunomodulatory properties as a CCR5 antagonist, we wanted to determine whether treatment impacted the expression of certain cytokines and chemokines in the lungs of the hamsters during infection, even if this did not influence the outcome. The gene discussed is CCR5; the disease is infection.